Early stroke and systemic embolism rates in patients following cardioversion for atrial fibrillation (A-fib) are low and comparable between those receiving warfarin or the novel oral anticoagulant ...
ANKARA, TURKEY — A strategy that takes advantage of the C in ICD (implantable cardioverter defibrillator), in which the device delivers a shock aimed at restoring sinus rhythm in patients with atrial ...
ENSURE-AF: Edoxaban noninferior to standard anticoagulation before cardioversion in patients with AF
Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation undergoing cardioversion, edoxaban conferred similar outcomes to the ...
The authors caution in the report that the trial was "underpowered to provide statistically rigorous results and was thus exploratory in nature." To heartwire,Cappato said an adequately powered trial ...
Oral anticoagulant therapy with rivaroxaban is a safe alternative to Vitamin K antagonist (VKA) therapy in patients with atrial fibrillation who are undergoing elective cardioversion to restore a ...
Delay in correcting atrial fibrillation irregular cardiac rhythm linked with increased complications
A delay of 12 hours or longer to correct an abnormal cardiac rhythm from atrial fibrillation was associated with a greater risk of thromboembolic complications such as stroke, according to a study. A ...
Medtronic alerted healthcare professionals in Europe to the risk of cardioversion-related damage to the Vanta implantable neurostimulator (INS), model 977006, During cardioversion, healthcare workers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results